Share Price and Basic Stock Data
Last Updated: November 8, 2025, 6:05 am
| PEG Ratio | 3.70 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Coromandel International Ltd, a prominent player in the fertiliser industry, reported a market capitalisation of ₹66,092 Cr with a share price of ₹2,241. The company has shown significant growth in revenue, with sales rising from ₹19,111 Cr in March 2022 to ₹29,628 Cr in March 2023. However, in the subsequent fiscal year, sales declined to ₹22,058 Cr, followed by a recovery to ₹24,085 Cr in March 2025. The trailing twelve months (TTM) revenue stood at ₹26,399 Cr, indicating a steady performance despite fluctuations. Quarterly sales also reflect variability, peaking at ₹10,113 Cr in September 2022 and declining to ₹3,913 Cr in March 2024. The operating profit margin (OPM) for the latest fiscal year remained stable at 11%, signalling consistent operational efficiency. Overall, while revenue trends exhibit volatility, Coromandel’s ability to maintain substantial sales levels positions it strategically within the sector.
Profitability and Efficiency Metrics
Coromandel International’s profitability metrics demonstrate resilience, with a reported net profit of ₹2,247 Cr and a net profit margin of 8.75% for the fiscal year ending March 2025. The return on equity (ROE) stood at 16.9%, and return on capital employed (ROCE) was recorded at 23.2%, both indicating healthy returns relative to the capital invested. The interest coverage ratio (ICR) of 11.38x highlights the company’s robust ability to meet interest obligations, well above typical sector standards. Furthermore, the company’s operating profit (₹2,577 Cr) reflects its operational efficiency, although the operating profit margin has remained relatively flat at 11% over recent years. The cash conversion cycle (CCC) has shown improvement, currently at -7 days, which is favourable compared to industry norms. Overall, Coromandel’s profitability and efficiency metrics underscore its strong financial health and operational effectiveness.
Balance Sheet Strength and Financial Ratios
Coromandel International’s balance sheet exhibits solid financial health, with total assets amounting to ₹18,917 Cr and total liabilities at ₹15,845 Cr, resulting in a manageable debt-to-equity ratio of 0.02. The company’s reserves have grown significantly, reaching ₹11,058 Cr in March 2025, providing a strong cushion for future investments and potential downturns. Borrowings stood at ₹780 Cr, reflecting prudent financial management with minimal reliance on debt. The book value per share increased to ₹376.37, indicating enhanced shareholder value. Important financial ratios such as the current ratio (1.89) and quick ratio (1.21) demonstrate adequate liquidity, ensuring the company can meet short-term obligations. Additionally, the enterprise value (EV) of ₹55,161.09 Cr compared to earnings before interest, taxes, depreciation, and amortisation (EBITDA) indicates a healthy valuation relative to earnings, suggesting that Coromandel is well-positioned in terms of balance sheet strength and financial ratios.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Coromandel International reflects a solid base of investor confidence, with promoters holding 56.90% of the equity. This is complemented by foreign institutional investors (FIIs) increasing their stake to 14.28%, while domestic institutional investors (DIIs) held 15.86% as of June 2025. The public shareholding now stands at 12.85%, indicating a diverse ownership structure. Notably, promoter holdings have shown a slight decline from 57.45% in September 2022, suggesting a gradual dilution of control, yet still maintaining a significant majority. The increase in FII participation indicates growing international confidence in the company’s prospects. Furthermore, the number of shareholders rose to 143,623, highlighting increasing retail investor interest. This diverse ownership structure along with the stability in promoter holdings underscores a robust investor confidence in Coromandel’s long-term growth potential.
Outlook, Risks, and Final Insight
Looking ahead, Coromandel International’s outlook appears promising, driven by its solid financial metrics and growing market presence. However, the company faces several risks, including potential fluctuations in raw material prices and changes in government policies affecting the fertiliser sector. The recent decline in sales from ₹29,628 Cr to ₹22,058 Cr showcases the volatility that can occur in agricultural markets. Additionally, while the company’s debt levels are low, any significant rise in interest rates could impact profitability. Despite these risks, Coromandel’s strong operational efficiency, healthy margins, and robust balance sheet offer a cushion against market uncertainties. Strategies focused on innovation and sustainability could enhance its competitive edge. In summary, while the company navigates challenges, its financial robustness and market position provide a solid foundation for future growth opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Coromandel International Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,443 Cr. | 187 | 231/156 | 11.6 | 305 | 2.68 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 168 Cr. | 31.8 | 85.0/30.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 127 Cr. | 14.0 | 21.5/11.0 | 28.8 | 19.6 | 0.36 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,056 Cr. | 251 | 395/155 | 3.05 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,816 Cr. | 89.2 | 128/66.2 | 11.4 | 58.9 | 2.24 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,788.48 Cr | 404.77 | 51.48 | 183.36 | 0.91% | 13.03% | 10.58% | 7.35 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,729 | 10,113 | 8,310 | 5,476 | 5,693 | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 |
| Expenses | 5,044 | 9,056 | 7,539 | 5,089 | 4,988 | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 |
| Operating Profit | 685 | 1,057 | 771 | 387 | 706 | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 |
| OPM % | 12% | 10% | 9% | 7% | 12% | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% |
| Other Income | 55 | 32 | 40 | 47 | 44 | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 |
| Interest | 27 | 54 | 57 | 52 | 41 | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 |
| Depreciation | 45 | 46 | 47 | 45 | 48 | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 |
| Profit before tax | 669 | 989 | 706 | 337 | 661 | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 |
| Tax % | 25% | 25% | 25% | 27% | 25% | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% |
| Net Profit | 499 | 741 | 527 | 246 | 494 | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 |
| EPS in Rs | 16.99 | 25.20 | 17.92 | 8.38 | 16.80 | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 |
Last Updated: August 1, 2025, 10:30 pm
Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,988.00 Cr. (Mar 2025) to 7,042.00 Cr., marking an increase of 2,054.00 Cr..
- For Expenses, as of Jun 2025, the value is 6,260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,579.00 Cr. (Mar 2025) to 6,260.00 Cr., marking an increase of 1,681.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 782.00 Cr.. The value appears strong and on an upward trend. It has increased from 409.00 Cr. (Mar 2025) to 782.00 Cr., marking an increase of 373.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 389.00 Cr..
- For Interest, as of Jun 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Mar 2025) to 68.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 36.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 677.00 Cr.. The value appears to be declining and may need further review. It has decreased from 731.00 Cr. (Mar 2025) to 677.00 Cr., marking a decrease of 54.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 26.00%, marking an increase of 5.00%.
- For Net Profit, as of Jun 2025, the value is 502.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2025) to 502.00 Cr., marking a decrease of 76.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 17.13. The value appears to be declining and may need further review. It has decreased from 19.67 (Mar 2025) to 17.13, marking a decrease of 2.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,053 | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 26,399 |
| Expenses | 9,246 | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 23,532 |
| Operating Profit | 808 | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 2,867 |
| OPM % | 8% | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 11% |
| Other Income | 46 | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 735 |
| Interest | 240 | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 273 |
| Depreciation | 96 | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 346 |
| Profit before tax | 517 | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 2,983 |
| Tax % | 29% | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | |
| Net Profit | 365 | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 2,247 |
| EPS in Rs | 12.59 | 13.80 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.30 | 52.08 | 68.46 | 55.78 | 70.14 | 76.72 |
| Dividend Payout % | 36% | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.14% | -11.19% | 33.61% | 44.86% | 4.20% | 47.92% | 24.79% | 14.97% | 31.74% | -18.48% | 25.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.33% | 44.81% | 11.25% | -40.67% | 43.72% | -23.13% | -9.82% | 16.77% | -50.22% | 43.71% |
Coromandel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 8% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 25% |
| 3 Years: | 31% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 23% |
| 3 Years: | 21% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: July 25, 2025, 3:23 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 2,253 | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 |
| Borrowings | 1,843 | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 |
| Other Liabilities | 3,481 | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 |
| Total Liabilities | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 |
| Fixed Assets | 1,734 | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 |
| CWIP | 74 | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 |
| Investments | 342 | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 |
| Other Assets | 5,455 | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 |
| Total Assets | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 |
Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 29.00 Cr..
- For Reserves, as of Mar 2025, the value is 11,058.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,390.00 Cr. (Mar 2024) to 11,058.00 Cr., marking an increase of 1,668.00 Cr..
- For Borrowings, as of Mar 2025, the value is 780.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 492.00 Cr. (Mar 2024) to 780.00 Cr., marking an increase of 288.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7,049.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,933.00 Cr. (Mar 2024) to 7,049.00 Cr., marking an increase of 1,116.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 18,917.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15,845.00 Cr. (Mar 2024) to 18,917.00 Cr., marking an increase of 3,072.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4,139.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,112.00 Cr. (Mar 2024) to 4,139.00 Cr., marking an increase of 1,027.00 Cr..
- For CWIP, as of Mar 2025, the value is 396.00 Cr.. The value appears strong and on an upward trend. It has increased from 235.00 Cr. (Mar 2024) to 396.00 Cr., marking an increase of 161.00 Cr..
- For Investments, as of Mar 2025, the value is 1,031.00 Cr.. The value appears strong and on an upward trend. It has increased from 854.00 Cr. (Mar 2024) to 1,031.00 Cr., marking an increase of 177.00 Cr..
- For Other Assets, as of Mar 2025, the value is 13,351.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,644.00 Cr. (Mar 2024) to 13,351.00 Cr., marking an increase of 1,707.00 Cr..
- For Total Assets, as of Mar 2025, the value is 18,917.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,845.00 Cr. (Mar 2024) to 18,917.00 Cr., marking an increase of 3,072.00 Cr..
Notably, the Reserves (11,058.00 Cr.) exceed the Borrowings (780.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 807.00 | 854.00 | 767.00 | 981.00 | -1.00 | -1.00 | -1.00 | -384.00 | -393.00 | -391.00 | -490.00 | -778.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 |
| Inventory Days | 86 | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 |
| Days Payable | 132 | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 117 | 123 |
| Cash Conversion Cycle | 7 | 12 | 15 | -3 | -2 | 30 | 22 | 2 | -1 | -7 | 8 | -7 |
| Working Capital Days | 4 | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 44 | 28 |
| ROCE % | 16% | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Emerging Equity Fund - Regular Plan | 7,423,311 | 2.51 | 850.93 | 7,423,311 | 2025-04-22 17:25:38 | 0% |
| DSP Mid Cap Fund | 5,065,035 | 3.86 | 580.61 | 5,065,035 | 2025-04-22 17:25:38 | 0% |
| Axis Midcap Fund | 4,652,378 | 2.35 | 533.3 | 4,652,378 | 2025-04-22 17:25:38 | 0% |
| SBI Magnum Midcap Fund | 3,778,182 | 3.27 | 433.09 | 3,778,182 | 2025-04-22 17:25:38 | 0% |
| Kotak Equity Opportunities Fund - Regular Plan | 2,450,000 | 1.81 | 280.84 | 2,450,000 | 2025-04-22 17:25:38 | 0% |
| Franklin India Prima Fund | 1,986,228 | 2.59 | 227.68 | 1,986,228 | 2025-04-22 17:25:38 | 0% |
| Sundaram Mid Cap Fund | 1,773,595 | 2.32 | 203.31 | 1,773,595 | 2025-04-22 17:25:38 | 0% |
| Sundaram Mid Cap Fund - Institutional Plan | 1,773,595 | 2.32 | 203.31 | 1,773,595 | 2025-04-22 17:25:38 | 0% |
| SBI Contra Fund | 1,771,410 | 1.24 | 203.06 | 1,771,410 | 2025-04-22 17:25:38 | 0% |
| DSP Equity Opportunities Fund | 1,298,134 | 1.63 | 148.81 | 1,298,134 | 2025-04-22 17:25:38 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 70.23 | 55.81 | 68.51 | 52.09 | 45.34 |
| Diluted EPS (Rs.) | 70.12 | 55.81 | 68.38 | 51.98 | 45.22 |
| Cash EPS (Rs.) | 81.42 | 64.39 | 75.49 | 57.83 | 51.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Revenue From Operations / Share (Rs.) | 817.56 | 749.27 | 1007.75 | 651.14 | 483.37 |
| PBDIT / Share (Rs.) | 101.39 | 89.34 | 105.35 | 78.16 | 70.19 |
| PBIT / Share (Rs.) | 91.54 | 81.57 | 99.16 | 72.28 | 64.29 |
| PBT / Share (Rs.) | 94.40 | 75.24 | 92.70 | 69.71 | 60.69 |
| Net Profit / Share (Rs.) | 71.56 | 56.63 | 69.30 | 51.95 | 45.12 |
| NP After MI And SOA / Share (Rs.) | 70.14 | 55.78 | 68.47 | 52.08 | 45.30 |
| PBDIT Margin (%) | 12.40 | 11.92 | 10.45 | 12.00 | 14.52 |
| PBIT Margin (%) | 11.19 | 10.88 | 9.83 | 11.10 | 13.30 |
| PBT Margin (%) | 11.54 | 10.04 | 9.19 | 10.70 | 12.55 |
| Net Profit Margin (%) | 8.75 | 7.55 | 6.87 | 7.97 | 9.33 |
| NP After MI And SOA Margin (%) | 8.57 | 7.44 | 6.79 | 7.99 | 9.37 |
| Return on Networth / Equity (%) | 18.63 | 17.43 | 25.45 | 24.03 | 25.80 |
| Return on Capital Employeed (%) | 22.59 | 24.04 | 34.79 | 31.11 | 33.71 |
| Return On Assets (%) | 10.91 | 10.35 | 14.14 | 13.54 | 14.94 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 1.39 | 1.47 | 2.32 | 1.90 | 1.48 |
| Current Ratio (X) | 1.89 | 2.07 | 1.75 | 1.87 | 1.98 |
| Quick Ratio (X) | 1.21 | 1.28 | 0.99 | 1.05 | 1.19 |
| Inventory Turnover Ratio (X) | 2.75 | 3.00 | 4.84 | 3.80 | 2.65 |
| Dividend Payout Ratio (NP) (%) | 17.08 | 10.75 | 17.51 | 23.03 | 39.70 |
| Dividend Payout Ratio (CP) (%) | 14.98 | 9.44 | 16.06 | 20.70 | 35.12 |
| Earning Retention Ratio (%) | 82.92 | 89.25 | 82.49 | 76.97 | 60.30 |
| Cash Earning Retention Ratio (%) | 85.02 | 90.56 | 83.94 | 79.30 | 64.88 |
| Interest Coverage Ratio (X) | 11.38 | 14.10 | 16.30 | 30.40 | 19.49 |
| Interest Coverage Ratio (Post Tax) (X) | 7.71 | 9.94 | 11.72 | 21.20 | 13.53 |
| Enterprise Value (Cr.) | 55161.09 | 28896.11 | 24436.79 | 21701.81 | 21993.08 |
| EV / Net Operating Revenue (X) | 2.29 | 1.31 | 0.82 | 1.14 | 1.55 |
| EV / EBITDA (X) | 18.47 | 10.99 | 7.89 | 9.46 | 10.68 |
| MarketCap / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| Retention Ratios (%) | 82.91 | 89.24 | 82.48 | 76.96 | 60.29 |
| Price / BV (X) | 5.26 | 3.36 | 3.27 | 3.69 | 4.41 |
| Price / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| EarningsYield | 0.03 | 0.05 | 0.07 | 0.06 | 0.05 |
After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 70.23. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.23, marking an increase of 14.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 70.12. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.12, marking an increase of 14.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.42. This value is within the healthy range. It has increased from 64.39 (Mar 24) to 81.42, marking an increase of 17.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 817.56. It has increased from 749.27 (Mar 24) to 817.56, marking an increase of 68.29.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.39. This value is within the healthy range. It has increased from 89.34 (Mar 24) to 101.39, marking an increase of 12.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.54. This value is within the healthy range. It has increased from 81.57 (Mar 24) to 91.54, marking an increase of 9.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 94.40. This value is within the healthy range. It has increased from 75.24 (Mar 24) to 94.40, marking an increase of 19.16.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 71.56. This value is within the healthy range. It has increased from 56.63 (Mar 24) to 71.56, marking an increase of 14.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 70.14. This value is within the healthy range. It has increased from 55.78 (Mar 24) to 70.14, marking an increase of 14.36.
- For PBDIT Margin (%), as of Mar 25, the value is 12.40. This value is within the healthy range. It has increased from 11.92 (Mar 24) to 12.40, marking an increase of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 10.88 (Mar 24) to 11.19, marking an increase of 0.31.
- For PBT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 10.04 (Mar 24) to 11.54, marking an increase of 1.50.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 8.75, marking an increase of 1.20.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.57. This value is within the healthy range. It has increased from 7.44 (Mar 24) to 8.57, marking an increase of 1.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.63. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 18.63, marking an increase of 1.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.59. This value is within the healthy range. It has decreased from 24.04 (Mar 24) to 22.59, marking a decrease of 1.45.
- For Return On Assets (%), as of Mar 25, the value is 10.91. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.91, marking an increase of 0.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.47 (Mar 24) to 1.39, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.89, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.21, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.75. This value is below the healthy minimum of 4. It has decreased from 3.00 (Mar 24) to 2.75, marking a decrease of 0.25.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.08. This value is below the healthy minimum of 20. It has increased from 10.75 (Mar 24) to 17.08, marking an increase of 6.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.98. This value is below the healthy minimum of 20. It has increased from 9.44 (Mar 24) to 14.98, marking an increase of 5.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.92. This value exceeds the healthy maximum of 70. It has decreased from 89.25 (Mar 24) to 82.92, marking a decrease of 6.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.02. This value exceeds the healthy maximum of 70. It has decreased from 90.56 (Mar 24) to 85.02, marking a decrease of 5.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.38. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 11.38, marking a decrease of 2.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 7.71, marking a decrease of 2.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 55,161.09. It has increased from 28,896.11 (Mar 24) to 55,161.09, marking an increase of 26,264.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 2.29, marking an increase of 0.98.
- For EV / EBITDA (X), as of Mar 25, the value is 18.47. This value exceeds the healthy maximum of 15. It has increased from 10.99 (Mar 24) to 18.47, marking an increase of 7.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For Retention Ratios (%), as of Mar 25, the value is 82.91. This value exceeds the healthy maximum of 70. It has decreased from 89.24 (Mar 24) to 82.91, marking a decrease of 6.33.
- For Price / BV (X), as of Mar 25, the value is 5.26. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 5.26, marking an increase of 1.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Coromandel International Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.59% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.63% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.8 (Industry average Stock P/E: 51.48)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Coromandel House, Secunderabad Telangana 500003 | investorsgrievance@coromandel.murugappa.com http://www.coromandel.biz |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A Vellayan | Chairman Emeritus |
| Mr. Arun Alagappan | Executive Chairman |
| Mr. Natrajan Srinivasan | Executive Vice Chairman |
| Mr. S Sankarasubramanian | Managing Director & CEO |
| Dr. Raghuram Devarakonda | Executive Director |
| Mr. Arunachalam Vellayan | Whole Time Director |
| Mr. Narayanan Vellayan | Whole Time Director |
| Mr. Sudarshan Venu | Independent Director |
| Dr. Deepali Pant Joshi | Independent Director |
| Mr. Adnan Ahmad | Independent Director |
| Mr. Aditya Himatsingka | Independent Director |
| Mr. Suresh Subramanian | Independent Director |
| Mr. Durgashankar Subramaniam | Independent Director |
FAQ
What is the intrinsic value of Coromandel International Ltd?
Coromandel International Ltd's intrinsic value (as of 08 November 2025) is 1673.28 which is 22.03% lower the current market price of 2,146.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 63,302 Cr. market cap, FY2025-2026 high/low of 2,720/1,590, reserves of ₹11,058 Cr, and liabilities of 18,917 Cr.
What is the Market Cap of Coromandel International Ltd?
The Market Cap of Coromandel International Ltd is 63,302 Cr..
What is the current Stock Price of Coromandel International Ltd as on 08 November 2025?
The current stock price of Coromandel International Ltd as on 08 November 2025 is 2,146.
What is the High / Low of Coromandel International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Coromandel International Ltd stocks is 2,720/1,590.
What is the Stock P/E of Coromandel International Ltd?
The Stock P/E of Coromandel International Ltd is 29.8.
What is the Book Value of Coromandel International Ltd?
The Book Value of Coromandel International Ltd is 413.
What is the Dividend Yield of Coromandel International Ltd?
The Dividend Yield of Coromandel International Ltd is 0.56 %.
What is the ROCE of Coromandel International Ltd?
The ROCE of Coromandel International Ltd is 23.2 %.
What is the ROE of Coromandel International Ltd?
The ROE of Coromandel International Ltd is 16.9 %.
What is the Face Value of Coromandel International Ltd?
The Face Value of Coromandel International Ltd is 1.00.